O. Lazari

发表

A putative neuromuscular acetylcholinesterase gene from Dictyocaulus viviparus.

M. Selkirk, J. Matthews, H. Ploeger, 2004, Molecular and biochemical parasitology.

Optimization of Potent and Selective Ataxia Telangiectasia-Mutated Inhibitors Suitable for a Proof-of-Concept Study in Huntington's Disease Models.

S. Dowler, M. Lamers, R. Cachope, 2019, Journal of medicinal chemistry.

Functional genomics of nematode acetylcholinesterases

M. Selkirk, J. Matthews, O. Lazari, 2005, Parasitology.

Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington’s Disease Pathology

T. Vogt, G. Mcallister, C. Dominguez, 2022, Journal of medicinal chemistry.

A tryptophan amphiphilic tetramerization domain-containing acetylcholinesterase from the bovine lungworm, Dictyocaulus viviparus

A. Davidson, M. Selkirk, J. Matthews, 2006, Parasitology.

Uptake, efficacy, and systemic distribution of naked, inhaled short interfering RNA (siRNA) and locked nucleic acid (LNA) antisense.

M. Yeadon, M. Frick, R. Subramanian, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Advances in Huntington Disease Drug Discovery

M. Wall, J. Bard, I. Muñoz-Sanjuán, 2014, Journal of biomolecular screening.

Identification of a LIM domain-containing gene in the Cyathostominae.

K. Matthews, J. Matthews, R. Craig, 2008, Veterinary parasitology.

Cloning and expression of two secretory acetylcholinesterases from the bovine lungworm, Dictyocaulus viviparus.

A. Davidson, M. Selkirk, J. Matthews, 2003, Molecular and biochemical parasitology.

Up‐regulated expression of the α7 nicotinic acetylcholine receptor subunit on inflammatory infiltrates during Dictyocaulus viviparus infection

A. Kipar, J. Matthews, M. Selkirk, 2006, Parasite immunology.

Nematode acetylcholinesterases are encoded by multiple genes and perform non-overlapping functions.

M. Selkirk, J. Matthews, A. Hussein, 2005, Chemico-biological interactions.

Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK).

Diane Joseph-McCarthy, Jon Read, Sameer Kawatkar, 2012, Journal of medicinal chemistry.

Identification and Optimization of RNA-Splicing Modulators as Huntingtin Protein-Lowering Agents for the Treatment of Huntington's Disease.

C. Dominguez, T. Heikkinen, T. Bolkvadze, 2023, Journal of medicinal chemistry.

Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease.

M. Lamers, R. Cachope, G. Mcallister, 2021, Journal of medicinal chemistry.